Provided by Tiger Trade Technology Pte. Ltd.

10x Genomics, Inc.

59.72
-1.8200-2.96%
Volume:614.35K
Turnover:36.71M
Market Cap:7.78B
PE:-101.50
High:61.64
Open:60.84
Low:58.70
Close:61.54
52wk High:66.94
52wk Low:11.16
Shares:130.29M
Float Shares:118.00M
Volume Ratio:0.86
T/O Rate:0.52%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5884
EPS(LYR):-0.3490
ROE:-9.40%
ROA:-5.05%
PB:9.43
PE(LYR):-171.09

Loading ...

10x Genomics and Cleveland Clinic Collaborate to Advance Research in Diagnostic Applications of Single Cell and Spatial Technologies in Patients With Bladder Cancer

THOMSON REUTERS
·
Jun 17

10x Genomics Buy Targets Proteomics To Deepen Multiomic Customer Relationships

Simply Wall St.
·
Jun 10

10x Genomics acquires Proteintech Genomics unit

Reuters
·
Jun 09

10x Genomics Acquires Proteintech Genomics, a Division Within Proteintech Group

THOMSON REUTERS
·
Jun 09

10x Genomics - Terms Not Disclosed; No Meaningful Near-Term Financial Impact Expected

THOMSON REUTERS
·
Jun 09

10x Genomics shareholders elected three Class I directors at annual meeting

Reuters
·
Jun 09

10x Genomics (TXG) Is Up 9.7% After Momentum Rally Despite Weak Fundamentals - What's Changed

Simply Wall St.
·
Jun 07

10x Genomics : Deutsche Bank Raises Target Price to $30 From $23

THOMSON REUTERS
·
Jun 03

A Look At 10x Genomics (TXG) Valuation After A Strong Year Of Share Price Momentum

Simply Wall St.
·
Jun 02

10x Genomics CEO Serge Saxonov sells USD 705,273 of Class A shares

Reuters
·
May 28

Is It Time To Reassess 10x Genomics (TXG) After Its 188% One Year Share Price Surge

Simply Wall St.
·
May 21

Citi hires Jaschke to lead West Coast life sciences tools M&A coverage

Reuters
·
May 21

10x Genomics Is Maintained at Equal-Weight by Morgan Stanley

Dow Jones
·
May 13

Morgan Stanley Lifts Price Target on 10x Genomics to $22 From $20, Keeps Equalweight Rating

MT Newswires Live
·
May 12

U.S. RESEARCH ROUNDUP-Accuray, Aevex, Zoetis

Reuters
·
May 12

Stock Track | 10x Genomics Plummets 8.52% Intraday After Q1 Report Shows Revenue Decline and License Revenue Plunge

Stock Track
·
May 08

Piper Sandler Keeps Their Hold Rating on 10x Genomics (TXG)

TIPRANKS
·
May 08

10x Genomics (TXG) Receives a Buy from Barclays

TIPRANKS
·
May 08

Stock Track | 10x Genomics Plunges 6.33% in Pre-Market Despite Earnings Beat as Revenue Declines and Analysts Revise Estimates

Stock Track
·
May 08

Analysts Offer Insights on Healthcare Companies: 10x Genomics (TXG) and Telix Pharmaceuticals (OtherTLPPF)

TIPRANKS
·
May 08